Research shows intentional weight loss in older adults can lead to better mobility, reduced medical complications, and ...

Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

The "Make America Healthy Again" report, commissioned by President Trump, highlights ultraprocessed foods and environmental ...

A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

LONDON, April 25 (Reuters Breakingviews) - The pecking order of the obesity drug market is shifting. Eli Lilly (LLY.N), opens new tab, the $815 billion maker of blockbuster weight-loss drugs ...